What is the price target for REPH stock?
9 analysts have analysed REPH and the average price target is 5.1 null. This implies a price increase of 144.02% is expected in the next year compared to the current price of 2.09.
RECRO PHARMA INC (REPH) Forecast, Price Target & Analyst Ratings
NASDAQ:REPH
Current stock price
2.09
-0.01 (-0.48%)
At close:
2.09
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RECRO PHARMA INC (REPH).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 4, 2022
- Period
- Q1 / 2022
- EPS Estimate
- -$0.08
- Revenue Estimate
- 19.807M
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.10
Upside
+ 144.02%
From current price of $2.09 to mean target of $5.10, Based on 9 analyst forecasts
Low
$4.04
Median
$5.10
High
$6.30
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for REPH. The average price target is 5.1 null. This implies a price increase of 144.02% is expected in the next year compared to the current price of 2.09.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
86.67%
REPH was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about REPH.
In the previous month the buy percentage consensus was at a similar level.
REPH was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-10-12 | William Blair | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 4, 2022
- Period
- Q1 / 2022
- EPS Estimate
- -$0.08
- Revenue Estimate
- 19.807M
- Revenue Q2Q
- 17.90%
- EPS Q2Q
- 63.04%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
REPH is expected to report earnings on 5/4/2022. The consensus EPS estimate for the next earnings is -0.08 null and the consensus revenue estimate is 19.81M null.
Full Analyst Estimates 2022 - 2025
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 99.22M 28.27% | 66.5M -32.98% | 75.36M 13.32% | 93.25M 23.74% | 102.149M 9.54% | 116.323M 13.88% | 135.113M 16.15% | |
| EBITDA YoY % growth | 32.03M 169.34% | 200K -99.38% | 7.98M 3,890.00% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 23.63M 143.73% | -8.34M -135.29% | 412K 104.94% | N/A | N/A | N/A | N/A | |
| Operating Margin | 23.82% | -12.54% | 0.55% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 0.20 108.03% | -1.15 -675.00% | -0.31 73.04% | -0.29 5.68% | -0.24 16.28% | -0.27 -8.71% | -0.30 -10.89% |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 63.04% | -0.04 -224.68% | -0.05 22.29% | -0.05 -35.99% | -0.09 -8.00% | -0.02 45.46% | -0.04 25.00% | -0.04 25.00% |
| Revenue Q2Q % growth | 19.807M 17.90% | 25.556M 41.84% | 24.192M 32.65% | 24.397M 9.39% | 21.379M 7.94% | 28.002M 9.57% | 25.99M 7.43% | 26.267M 7.67% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
4.51%
EPS Next 5 Year
1.18%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
15.26%
Revenue Next 5 Year
15.49%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
RECRO PHARMA INC / REPH Forecast FAQ
When does RECRO PHARMA INC (REPH) report earnings?
RECRO PHARMA INC (REPH) will report earnings on 2022-05-04.
Can you provide the consensus estimates for RECRO PHARMA INC next earnings?
The consensus EPS estimate for the next earnings of RECRO PHARMA INC (REPH) is -0.08 null and the consensus revenue estimate is 19.81M null.
Can you provide the analyst count for RECRO PHARMA INC stock?
The number of analysts covering RECRO PHARMA INC (REPH) is 9.